Table 2. Mean Risk Index Scores at Randomization in 324 patients from OPTIMA.
Patients per Category | Mean Score (SD) | ||
Number (%) | Restricted Index | VACS Index | |
Age (years) | 10.7 (12.9) | 5.7 (7.1) | |
<50 | 184 (56.8) | ||
50 to 64 | 128 (39.5) | ||
≥65 | 12 (3.7) | ||
CD4 (cells/mm3) | 27.2 (15.0) | 16.8 (10.3) | |
≥500 | 2 (0.6 ) | ||
200 to 499 | 83 (25.6) | ||
100 to 199 | 102 (31.5) | ||
50 to 99 | 44 (13.6) | ||
<50 | 93 (28.7) | ||
HIV-1 RNA (copies/ml) | 16.0 (6.9) | 9.5 (3.5) | |
<500 | 2 (0.6 ) | ||
500 to 1×105 | 204 (63.0) | ||
≥1×105 | 118 (36.4) | ||
Hemoglobin (g/dL) | 7.3 (8.6) | ||
≥14 | 152 (41.7) | ||
12 to 13.9 | 130 (40.1) | ||
10 to 11.9 | 34 (10.5) | ||
<10 | 8 (15.7) | ||
FIB-4 | 6.5 (8.5) | ||
<1.45 | 135 (41.7) | ||
1.45 to 3.25 | 138 (42.6) | ||
>3.25 | 51 (15.7) | ||
eGFR mL/min | 0.7 (3.5) | ||
≥60 | 305 (94.1) | ||
45 to 59.9 | 3 (0.9) | ||
30 to 44.9 | 11 (3.4) | ||
<30 | 5 (1.5) | ||
Hepatitis C Infection | 1.2 (2.1) | ||
Present | 76 (23.5) | ||
Absent | 148 (76.5) | ||
Total Score | 53.9 (20.5) | 42.0 (20.3) | |
Min-Max Range | 21–115 | 13–110 |
FIB4: (years of age×AST)/(platelets in 109/L×square root of ALT).
ALT: alanine transaminase.
AST: aspartate transaminase.
eGFR: 186.3×(serum creatinine−1.154)×(age−0.203)×(0.742 for women×(1.21 if black).